Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Amy Mallorie"'
Autor:
Muram El-Nayir, Rohan Wijesurendra, David Preiss, Marion Mafham, Leandros Tsiotos, Sadman Islam, Anne Whitehouse, Sophia Wilkinson, Hannah Freeman, Ryonfa Lee, Wojciech Brudlo, Genna Bobby, Bryony Jenkins, Robert Humphrey, Amy Mallorie, Andrew Toal, Elnora C. Barker, Dianna Moylan, Graeme Thomson, Firoza Davies, Hameed Khan, Ian Allotey, Susan Dickie, John Roberts
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Introduction ASCEND PLUS is a randomised controlled trial assessing the effects of oral semaglutide on the primary prevention of cardiovascular events in around 20,000 individuals with type 2 diabetes in the UK. The trial’s innovative desi
Externí odkaz:
https://doaj.org/article/b74ceea0031f4a2bb283e5bb323fb6bc
Autor:
Amy Mallorie, Brian Shine
Publikováno v:
Surgery (Oxford). 40:163-168
Autor:
Matthew Stubbs, Thomas Wagner, Amy Mallorie, Stefanos Ioannidis, Shaunak Navalkissoor, Kenneth H. Chan
Publikováno v:
Nuclear Medicine Communications. 39:618-620
OBJECTIVES: The risk of recurrent venous thromboembolic disease and the management of patients with isolated subsegmental pulmonary embolism (SSPE) remain unclear. We sought to assess the long-term clinical outcome of patients with isolated SSPE demo
Publikováno v:
Nuclear medicine communications. 38(8)
Objectives Lymph node involvement in non-small-cell lung cancer (NSCLC) is a major factor in determining management and prognosis. We aimed to evaluate the accuracy of fluorine-18-fluorodeoxyglucose-PET/computed tomography (CT) for the assessment of
Autor:
Thomas E Cowling, Sanjay K Prasad, James C. Moon, Rory O'Hanlon, Ricardo Wage, Ankur Gulati, Tevfik F Ismail, Bibek Das, Andrew Jabbour, Perry M. Elliott, Jahanzaib Khwaja, Dudley J. Pennell, William J. McKenna, Sadaf Raza, Carl Shakespeare, Amy Mallorie, Francisco Alpendurada, Amanda Varnava, Michael Roughton, Stuart A. Cook, Martin R. Cowie
Publikováno v:
Heart (British Cardiac Society). 100(23)
Myocardial fibrosis identified by late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) in patients with hypertrophic cardiomyopathy (HCM) is associated with adverse cardiovascular events, but its value as an independent risk fact
Publikováno v:
Gastroenterology. 150:S646
Autor:
Andrew Jabbour, Thomas E Cowling, Dudley J. Pennell, Sanjay K Prasad, Bibek Das, Ankur Gulati, Ricardo Wage, Tevfik F Ismail, Amy Mallorie
Publikováno v:
Journal of the American College of Cardiology. 59(13)
Autor:
Sanjay K Prasad, Niraj Mistry, Dudley J. Pennell, Taigang He, Ankur Gulati, Rick Wage, Andrew Jabbour, Benjamin Hewins, Amy Mallorie, Tevfik F Ismail
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 14, Iss Suppl 1, p P167 (2012)
Journal of Cardiovascular Magnetic Resonance
Journal of Cardiovascular Magnetic Resonance
Background Hypertrophic cardiomyopathy (HCM) is associated with increased myocardial fibrosis and collagen deposition. Collagen reduces cardiovascular magnetic resonance (CMR) derived T2 times, however, the inflammatory milieu required for its deposi
Autor:
Benjamin Hewins, Andrew Jabbour, Dudley J. Pennell, Sanjay K Prasad, Tevfik F Ismail, Niraj Mistry, Ricardo Wage, Amy Mallorie, Francisco Alpendurada, Natasha Davendralingam, Ankur Gulati
Publikováno v:
Journal of the American College of Cardiology. (13):E1065
Abnormalities of the coronary microvasculature are thought to be a histological hallmark of hypertrophic cardiomyopathy (HCM). We sought to determine the prevalence of microvascular ischemia in HCM using stress perfusion cardiovascular magnetic reson
Autor:
Sanjay K Prasad, Tevfik F Ismail, Jahanzaib Khwaja, Amanda Varnava, Ankur Gulati, Andrew Jabbour, Dudley J. Pennell, Thomas E Cowling, Michael Roughton, Bibek Das, Carl Shakespeare, Ricardo Wage, Sadaf Raza, Amy Mallorie
Publikováno v:
Journal of the American College of Cardiology. (10):E1272
Extreme left ventricular hypertrophy (LVH), defined on echo as a maximum LV wall thickness of ≥30 mm is regarded as a risk factor for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM). Cardiovascular magnetic resonance (CMR) is increa